LIPELLA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7279 USD | +0.40% |
|
+1.65% | -28.64% |
| Apr. 17 | Lipella Pharmaceuticals Inc. Appoints Jason Hafron and Pradeep Tyagi to Scientific Advisory Board | CI |
| Apr. 09 | Maxim Initiates Lipella Pharmaceuticals at Buy Rating With $2 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.8000 | 0.9600 | 1.150 |
| Spread/Res. | -9.01% | -24.18% | -36.70% |
| Spread/Supp. | +8.06% | +8.06% | +7.22% |
| Support | 0.6736 | 0.6736 | 0.6789 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LIPO Stock
- Charts Lipella Pharmaceuticals Inc.
